Oslo, 24 May 2018 – Navamedic ASA announces the finalisation of the Sippi® wireless connectivity solution to Patient Data Monitoring Systems (PDMS). The company has appointed a renowned adviser for the process of maximising the value of Sippi® and is evaluating several strategic alternatives for the global Sippi® launch.
“Navamedic is proud to announce the completion of the wireless connectivity solution for Sippi, offering a new standard for urine monitoring in hospitals by enabling automated digital measurement fully connected to the hospitals’ own patient systems. We have a back-log of 30 clinics across Europe waiting to test the first wireless PDMS-connected digital urinometer on the market, and are reviewing several strategic alternatives to accelerate and leverage the Sippi growth opportunity,” says Tom Rönnlund, Chief Executive Officer of Navamedic.
Sippi® is a new standard for urine monitoring which enables automated digital measurement. The Sippi® system represents a new and improved way of monitoring urine output, the last manual and non-digitalised vital parameter within the Intensive Care Unit (ICU).
“Wireless communication with PDMS-systems is recognised as a significant advancement in automating and digitalising all vital parameters of ICU patients, and our new solution will shortly enter into clinical validation at Uppsala University Hospital,” says Rönnlund, and continues:
“Navamedic sees significant worldwide opportunities with a wireless-connected Sippi and has appointed a renowned, internationally established adviser for the process of maximising the value of Sippi and evaluating several strategic alternatives for the global Sippi launch.”